Prevest Denpro Ltd
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
- Market Cap ₹ 469 Cr.
- Current Price ₹ 391
- High / Low ₹ 608 / 332
- Stock P/E
- Book Value ₹ 66.8
- Dividend Yield 0.26 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.85 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Dividend Payout % |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Equity Capital |
Reserves |
Preference Capital |
Total Liabilities |
CWIP |
Investments |
Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Debtor Days |
Inventory Days |
Days Payable |
Cash Conversion Cycle |
Working Capital Days |
ROCE % |
Documents
Announcements
- Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended March 31, 2024 1d
- Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended March 31, 2024 3 May
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr
- Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024 20 Apr
- Compliance Certificate Issued Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended 31St March, 2024 18 Apr
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Feb 2022TranscriptPPT
-
Dec 2021TranscriptPPT
Product Portfolio
Company manufactures over 100 dental products which comprise of:
a) Clinical Products: Adhesives, Bonding Agents & Etchants, Auxiliaries, Cement and Liners, Composites, Endodontics, Finishing & Polishing, Impression Materials, Oral Care, Orthodontics, Retraction Materials, Temporaries, and Tooth Whitening. [1]
b) Laboratory Products: Acrylics, Auxiliaries, Base Plates & Waxes, and Gypsum Products. [2]
Marquee Product - Resins: Company is the leading manufacturer of high-quality 3D printing resins designed for fabrication of dental crowns, bridges, inlays, onlays, and veneers. It offers several advantages over traditional fabrication methods.[3]
** Hygiene & Disinfectant** : This product is specifically formulated to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi. These products are designed to target high-touch surfaces, medical devices, and equipment.[4]
Product Application
Their dental products find application in endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and for fabrication of prosthesis in dental laboratories. [5]
Prevest Denpro Limited operates with a business model focused on the manufacturing and distribution of dental materials and equipment.[6]